<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03915743</url>
  </required_header>
  <id_info>
    <org_study_id>AIR</org_study_id>
    <nct_id>NCT03915743</nct_id>
  </id_info>
  <brief_title>Advance Care Planning Individualised Approach and Research Projec</brief_title>
  <acronym>AIR</acronym>
  <official_title>The AIR Project - Advance Care Planning Individualised Approach and Research Project. A Single Center Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Herlev and Gentofte Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Herlev and Gentofte Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will investigate the effect of a palliative approach in the out-patient management&#xD;
      of patients with COPD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomised control trial. A total of 90 patients will be randomise 1:1 to either palliative&#xD;
      intervention or standard care.&#xD;
&#xD;
      The intervention group will receive follow up in a newly established outpatient clinic for&#xD;
      COPD in the specialized palliative united and the control group will receive standard follow&#xD;
      up in the respiratory out-patient clinic.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    COVID-19&#xD;
  </why_stopped>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Actual">November 1, 2020</completion_date>
  <primary_completion_date type="Actual">November 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>RCT</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline in total Hospital and Anxiety Depression scale (HADS) at 6 months</measure>
    <time_frame>baseline, 3 and 6 months</time_frame>
    <description>questionnaire measuring anxiety and Depression in 2 subscales in this study we use the total value of the 2 subscales combined. The higher the number the worse the psychological impact. HADS total was a range from 0 to 24 where 0 is no psychological distress</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline EORTC QLQ-C15-PAL at 6 months</measure>
    <time_frame>baseline, 3 and 6 months</time_frame>
    <description>questionnaire, consists of 14 questions and a license audit goal from 1 to 7 where 7 is the best possible quality of life.For the first 14 questions about symptoms, the scale goes from 1 to 4 where 4 is the worst</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Life-Space Assessment (LSA) at 6 months</measure>
    <time_frame>baseline, 3 and 6 months</time_frame>
    <description>questionnaire,5 questions about where the patient has been in the last 4 weeks. Question 1 is other than bedroom and question 5 is out of his home town. In addition, questions are asked about how frequently and on the use of aids.finally the scales are converted to numerical value between 0 and 120 where 0 is worst and expresses that the patient is constant in bed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline copd assessment test (CAT) at 6 months</measure>
    <time_frame>baseline, 3 and 6 months</time_frame>
    <description>questionnaire. 8 items questionnaire where there should be between 0 and 5 where 5 is the worst. Together, this gives a total scale between 0 and 40 where 40 is worst</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Adherence at 6months</measure>
    <time_frame>6 months</time_frame>
    <description>measured by inhaled medicine bought at the pharmacy. Data is gather from a national database</description>
  </other_outcome>
  <other_outcome>
    <measure>Change from Baseline Use of out-patient clinic at 6 months</measure>
    <time_frame>baseline to 6 months</time_frame>
    <description>number of out-patient clinic visits</description>
  </other_outcome>
  <other_outcome>
    <measure>Change from Baseline in admission frequency at 6 months</measure>
    <time_frame>baseline to 6 month</time_frame>
    <description>numbers of admissions in the study periode</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Severe COPD</condition>
  <arm_group>
    <arm_group_label>Palliative care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Specialized palliative care arm in a newly formed COPD outpatient clinic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care in a standard pulmonary out-patient clinic. Treatment as described in national standards.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>palliative care</intervention_name>
    <description>complex and multi-faceted individualized palliative care</description>
    <arm_group_label>Palliative care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  • Diagnosis of COPD by spirometry&#xD;
&#xD;
               -  Patients followed in Herlev and Gentofte hospitals' respiratory&#xD;
                  out-patient-clinics or admitted to Herlev or Gentofte hospital for acute&#xD;
                  exacerbation&#xD;
&#xD;
               -  2 or more admissions for acute exacerbation of COPD within the last 12 months&#xD;
&#xD;
               -  CAT &gt; 20&#xD;
&#xD;
               -  Cognitive and linguistic able to understand and give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • Expected remaining life time less than 6 months due to other disease than COPD e.g.&#xD;
             active cancer&#xD;
&#xD;
               -  Participating in other studies&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens-Ulrik Jensen, Phd MD</last_name>
    <role>Study Director</role>
    <affiliation>pulmonary department Herlev and Gentofte Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Torgny Wilcke Wilcke, phd MD</last_name>
    <role>Study Director</role>
    <affiliation>pulmonary department Herlev and Gentofte Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Janni Mendahl, APN</last_name>
    <role>Study Director</role>
    <affiliation>Palliative unite Herlev and Gentofte Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Charlotte Ulrik, Prof. MD DMSc</last_name>
    <role>Study Director</role>
    <affiliation>Pulmonary department Hvidovre Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nina Godtfredsen, phd MD</last_name>
    <role>Study Chair</role>
    <affiliation>Pulmonary department Hvidovre Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kristoffer Marså, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Palliative Unite Herlev and Gentofte Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Herlev &amp; Gentofte hoospital</name>
      <address>
        <city>Copenhagen</city>
        <state>Herlev/ Reghion H</state>
        <zip>2730</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 27, 2019</study_first_submitted>
  <study_first_submitted_qc>April 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2019</study_first_posted>
  <last_update_submitted>February 9, 2021</last_update_submitted>
  <last_update_submitted_qc>February 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Herlev and Gentofte Hospital</investigator_affiliation>
    <investigator_full_name>Kristoffer Marsaa</investigator_full_name>
    <investigator_title>Head of section, senior consultant MD</investigator_title>
  </responsible_party>
  <keyword>Palliative care</keyword>
  <keyword>Out-patient clinic</keyword>
  <keyword>COPD symptom burden</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

